A volunteer in AstraZeneca’s Covid-19 vaccine trial has died in Brazil, the country’s National Health Surveillance Agency said Wednesday.
The agency, Anvisa, said in a statement that it was formally notified of the death on Monday.
The vaccine candidate is being developed with the University of Oxford.
In a statement to NBC News, AstraZeneca said that the trial would continue.
“We cannot comment on individual cases in an ongoing trial of the Oxford vaccine as we adhere strictly to medical confidentiality and clinical trial regulations, but we can confirm that all required review processes have been followed,” the statement said. “All significant medical events are carefully assessed by trial investigators, an independent safety monitoring committee and the regulatory authorities. These assessments have not led to any concerns about continuation of the ongoing study.”
Read more: Volunteer in AstraZeneca Covid-19 vaccine trial dies in Brazil
